Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • FED retains dovish stance and markets rise
    • Market Update

    FED retains dovish stance and markets rise

    The XJO is expected to rally on open this morning following a surge higher in the U.S overnight. Their futures are flat. The Fed maintained a dovish tone, fueling further gains overseas, and at this stage our market is happy to follow along. We should flirt with 7,750 on open this morning as we did

    Read More
    Public
  • Adacel receives $10.2m order for training simulations from Federal Aviation Administration
    • News

    Adacel receives $10.2m order for training simulations from Federal Aviation Administration

    After a troubling half complete with delays, losses and adjusted forecasts, Adacel Technologies (ASX: ADA), a company providing advanced air traffic management and air traffic control simulation solutions, has secured a new contract from its existing customer, the US-based Federal Aviation Administration (FAA). This infuses confidence in the Company, which is attempting a return to

    Read More
    Public
  • Softer infant formula demand in Middle East, China and EU squeeze Clover’s profits
    • News

    Softer infant formula demand in Middle East, China and EU squeeze Clover’s profits

    In 2023, global birth rates dipped by 1.15% per 1000 people, with significant declines noted in the EU (5.9%) and China (2.3%), extending a five-year trend. Consequently, all stages of infant formula production, from birth to growing milk, have declined. As a result, Clover Corporation (ASX: CLV), an Aussie tech company specialising in infant formula

    Read More
    Public
  • US shares trade back to highs ahead of key Fed meeting
    • Market Update

    US shares trade back to highs ahead of key Fed meeting

    The XJO is expected to edge higher on open this morning following a rally in the U.S overnight which saw their market return back to all-time high resistance. Yesterday we managed to crawl higher, but we arguably held resistance at roughly 7,700. This morning we should clear it, albeit meekly. We continue to trade in

    Read More
    Public
  • Universal Biosensors receives FDA approval for its blood coagulation device
    • News

    Universal Biosensors receives FDA approval for its blood coagulation device

    Aussie biosensor company Universal Biosensors (ASX: UBI) has received the US FDA 510(k) and CLIA Waiver approval for its Xprecia Prime Coagulation Analyzer as a Class II device. Xprecia Prime is a portable coagulation monitoring device that provides fast and accurate PT/INR testing (measuring how long it takes for blood to clot) specifically for patients

    Read More
    Public
  • Pentanet teams up with NVIDIA to expand global graphics delivery network
    • News

    Pentanet teams up with NVIDIA to expand global graphics delivery network

    Perth-based telco company Pentanet Limited (ASX: 5GG) has collaborated with NVIDIA to upgrade its cloud infrastructure. Integrating NVIDIA L40 GPUs into Pentanet’s Gen 3 cloud infrastructure has enabled the company to join NVIDIA’s Graphics Delivery Network (GDN), extending its reach to over 130 countries. The move to join NVIDIA GDN signifies Pentanet’s intention to broaden

    Read More
    Public
  • «
  • ‹
  • 103
  • 104
  • 105
  • 106
  • 107
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.